Bevacizumab biosimilars have the potential to expand access and reduce costs without compromising patient outcomes in ...

Fever increases immune cell metabolism, proliferation, and activity, but it also causes mitochondrial stress, DNA damage, and ...

This multiyear follow-up of more than 3300 patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL) who ...

Along with the Oncology Brothers, Paolo Tarantino, MD, discusses the post -hoc subgroup analysis from the EMERALD study ...

Social media and satellite data reveal a strong link between outdoor artificial light at night and rising insomnia rates in ...

(HealthDay News) — Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use may reduce alcohol consumption and improve outcomes in some individuals, according to a study published online Nov. 14 in ...

In the food and beverages group, the main subgroup of food at home increased 0.6% from 0.4% in September, mainly owing to an increase in the price of meat. Groups that recorded slower rates of price ...

Likewise, the investigators did not see any differences between the study arms concerning AEs. “In the subgroup analysis, we ...

Higher Life’s Essential 8 (LE8) scores, especially those reflecting lower nicotine exposure and better sleep health, are ...

A number of adults with outpatient medically attended respiratory syncytial virus (MA-RSV) infection experience ...

Bright light therapy improves remission and response rates in nonseasonal depression, enhances antidepressant effectiveness, ...

The impact of GLP-1 RAs on alcohol use is explored, showing potential benefits in reducing intake and cravings, but with ...